Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Public ClinicalTrials.gov record NCT03745638. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the efficacy and safety of twice daily ruxolitinib cream in adolescents and adults with Atopic Dermatitis (AD).
Study identification
- NCT ID
- NCT03745638
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 631 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 20, 2018 (Actual)
- Primary completion
- Dec 23, 2019 (Actual)
- Completion
- Dec 1, 2020 (Actual)
- Last update posted
- Sep 28, 2023
2018 – 2020
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology | Birmingham | Alabama | 35244 | — |
| Elite Clinical Studies | Phoenix | Arizona | 85018 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Dermatology Specialists Inc | Oceanside | California | 92056 | — |
| Integrated Research Group Inc. | Riverside | California | 92506 | — |
| Advanced Rx Clinical Research | Westminster | California | 92683 | — |
| Clearlyderm Boca Raton - BTC - PPDS | Boca Raton | Florida | 33433 | — |
| Olympian Clinical Research | Largo | Florida | 33770 | — |
| Acevedo Clinical Research | Miami | Florida | 33142 | — |
| Well Pharma Medical Research Corporation | Miami | Florida | 33143 | — |
| AdvancedPharma CR LLC | Miami | Florida | 33147 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| ForCare Clinical Research | Tampa | Florida | 33624 | — |
| Metabolic Research Institute Inc | West Palm Beach | Florida | 33401 | — |
| Aeroallergy Research Lab Of Savannah | Savannah | Georgia | 31406 | — |
| Clinical Research Atlanta - ERN-PPDS | Stockbridge | Georgia | 30281 | — |
| Sneeze Wheeze and Itch Associates LLC | Normal | Illinois | 61761 | — |
| Dawes Fretzin Clinical Research Group LLC | Indianapolis | Indiana | 46256 | — |
| DS Research | New Albany | Indiana | 47150 | — |
| Kansas City Dermatology P.A. | Overland Park | Kansas | 66215 | — |
| Skin Sciences, PLLC | Louisville | Kentucky | 40217 | — |
| Michael W Simon MD | Nicholasville | Kentucky | 40356 | — |
| DermAssociates | Rockville | Maryland | 20850 | — |
| Henry Ford Medical Center | Detroit | Michigan | 48202 | — |
| JDR Dermatology Research | Las Vegas | Nevada | 89148 | — |
| Forest Hills Dermatology Group | Forest Hills | New York | 11375 | — |
| Sadick Dermatology | New York | New York | 10075 | — |
| Wake Research Associates, LLC | Raleigh | North Carolina | 27612 | — |
| Ohio Pediatric Research Assn Inc | Huber Heights | Ohio | 45424 | — |
| Central Sooner Research | Norman | Oklahoma | 73071 | — |
| Cyn3rgy Research - Clinedge - PPDS | Gresham | Oregon | 97030 | — |
| Clinical Research Institute Of Southern Oregon - Crisor | Medford | Oregon | 97504 | — |
| Oregon Medical Research Center PC | Portland | Oregon | 97223 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Synexus Clinical Research Us Inc. Greer | Greer | South Carolina | 29651 | — |
| Alliance for Multispecialty Research, LLC | Knoxville | Tennessee | 37920 | — |
| Family Medicine Associates Of Texas | Carrollton | Texas | 75010 | — |
| Progressive Clinical Research PA | San Antonio | Texas | 78213 | — |
| Jordan Valley Medical Center | West Jordan | Utah | 84088 | — |
| PI Coor Clinical Research LLC | Burke | Virginia | 22015 | — |
| West End Dermatology | Henrico | Virginia | 23233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03745638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2023 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03745638 live on ClinicalTrials.gov.